Tag: Sysmex America Inc.

NEWSMAKER INTERVIEW: Ralph Taylor, CEO of Sysmex America

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures. Core laboratories have something unique and irreplaceable. Core laboratories will continue to anchor lab testing services in the communities they serve. What

View Article

Newsmaker Interview: Healthcare’s Transformation Now Bringing Changes to Lab Industry

“Today, patients want to get diagnosis and treatment faster with fewer visits to the doctor’s office. They want speedier and more comprehensive delivery of clinical services, be it laboratory tests, imaging, or other procedures.”

—Ralph Taylor, President, Sysmex America, Inc.

CEO Summary: To bring testing closer to patients, clinical laboratories will need to offer sophisticated point-of-care systems

View Article

FDA CLEARS WAIVED CBC FOR NEAR-PATIENT TESTING

CEO SUMMARY: Market clearance of the first-ever CLIA waived analyzer for complete blood count and three-part differential tests could cut time-to-answer from days to mere minutes for one of the top 20 tests by volume performed at core laboratories. Developer Sysmex America, Inc., foresees its analyzer as a complement to central labs. Basic diagnostics would

View Article

June 1, 2015 Intelligence: Late Breaking Lab News

Intelligence Late & Latent News

It’s a laboratory acquisition that is worth US$1.3 billion. In Europe, Cinven, a private equity company, will acquire Labco SA of Paris, France. Labco operates medical laboratories in France, Spain, Italy, Portugal, Belgium, and the United Kingdom. It reports annual revenue of US$714 million, performs 150 million clinical laboratory tests yearly, and employs more than 6,000 people.

View Article